2020 marks Singclean Medical’s 17th anniversary of establishment, with our great employees and our pursuit of excellence, Singclean has grown from a small company with 30 people, specialising in the development and manufacture of anti-adhesion products to an international enterprise now having more than 300 staff and playing a major part in shaping the future of absorbable biomaterials industry. Singclean’s main innovations including injectable hyaluronic acid-based products, stop bleeding products, in vitro diagnostic test kits and natural cosmetics, are currently available in over 70 countries around the world.
The most obvious sign of Singclean’s growth is that the industrial base is expanded from 3,320 m2 to 13,000 m2 and moved from the Fuyang District to Xiasha New Area where many medical centers and Zhejiang’s top universities are located.
This year, despite all the challenges that have come with the COVID-19 outbreak, Singclean still decides to carry out the expansion plan and invest 100 million RMB (approximately $14 million USD) to build a new research and innovation center focused on strengthening our ability to serve more patients with high-quality, innovative medical devices and attracting the best talent to work for Singclean Medical.
Building Rendering
This new 15,267 m2 research and innovation center with 8 floors is even bigger than the current industrial base and includes R&D laboratories, laboratory animal rooms, workshops, office relaxation area as well as a parking lot.
Right now, Singclean has broken the ground for the new building and it is estimated to put into operation in May, 2021.
This investment certainly displays our determination and ambition to lead the absorbable biomaterial industry.
-
singclean | 2020-05-27
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial. -
singclean | 2020-05-27
Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen -
singclean | 2020-05-27
Singclean Medical Shines at WHX Kuala Lumpur 2025, IVD Solutions Garner Strong Attention Across ASEANKuala Lumpur, Malaysia | July 18, 2025 — From July 16 to 18, WHX Kuala Lumpur 2025, one of ASEAN’s most influential exhibitions for medical devices and laboratory equipment, took place in the Malaysian capital. The event gathered global healthcare technology leaders, and Singclean Medical, a leading Chinese in-vitro diagnostics (IVD) company, made a strong impression with its innovative and reliable total IVD solutions. Backed by solid product performance and technological excellence, Singclean attracted wide interest and recognition from professional attendees.
